ABCL
Price
$2.23
Change
+$0.14 (+6.70%)
Updated
Apr 2, 02:27 PM (EDT)
Capitalization
663.02M
41 days until earnings call
CRSP
Price
$34.14
Change
+$1.00 (+3.02%)
Updated
Apr 2, 04:13 PM (EDT)
Capitalization
2.92B
40 days until earnings call
Ad is loading...

ABCL vs CRSP

Header iconABCL vs CRSP Comparison
Open Charts ABCL vs CRSPBanner chart's image
AbCellera Biologics
Price$2.23
Change+$0.14 (+6.70%)
Volume$600
Capitalization663.02M
CRISPR Therapeutics AG
Price$34.14
Change+$1.00 (+3.02%)
Volume$2.1K
Capitalization2.92B
ABCL vs CRSP Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CRSP commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and CRSP is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ABCL: $2.09 vs. CRSP: $33.14)
Brand notoriety: ABCL and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 105% vs. CRSP: 101%
Market capitalization -- ABCL: $663.02M vs. CRSP: $2.92B
ABCL [@Biotechnology] is valued at $663.02M. CRSP’s [@Biotechnology] market capitalization is $2.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than CRSP.

Price Growth

ABCL (@Biotechnology) experienced а -17.39% price change this week, while CRSP (@Biotechnology) price change was -18.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.91%. For the same industry, the average monthly price growth was -7.11%, and the average quarterly price growth was -11.65%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

CRSP is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($2.92B) has a higher market cap than ABCL($663M). CRSP YTD gains are higher at: -15.803 vs. ABCL (-28.669). ABCL has higher annual earnings (EBITDA): -204.15M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. ABCL (626M). ABCL has less debt than CRSP: ABCL (65.4M) vs CRSP (224M). CRSP has higher revenues than ABCL: CRSP (35M) vs ABCL (28.8M).
ABCLCRSPABCL / CRSP
Capitalization663M2.92B23%
EBITDA-204.15M-447.31M46%
Gain YTD-28.669-15.803181%
P/E RatioN/AN/A-
Revenue28.8M35M82%
Total Cash626M1.9B33%
Total Debt65.4M224M29%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCRSP
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MNDGX13.520.04
+0.30%
MFS New Discovery R1
PRSVX49.81N/A
N/A
T. Rowe Price Small-Cap Value
TVFVX59.86N/A
N/A
Third Avenue Value Investor
WFEHX13.54N/A
N/A
Allspring International Equity R6
PBSYX13.38N/A
N/A
Polen US Small Company Growth Y

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-6.28%
CRSP - ABCL
57%
Loosely correlated
-2.62%
NTLA - ABCL
56%
Loosely correlated
-6.40%
VCYT - ABCL
56%
Loosely correlated
-0.30%
BEAM - ABCL
55%
Loosely correlated
-9.70%
ABSI - ABCL
53%
Loosely correlated
-4.38%
More